Logo
LUMI PRO Eyes PN Skin Booster | 1x1ml per pack | Polynucleotide (PN) 5 mg/ml

LUMI PRO Eyes PN Skin Booster | 1x1ml per pack | Polynucleotide (PN) 5 mg/ml

LUMI-PRO

Injectable skin booster
  • Professional Use injectable skin booster marketed in the UK/EU for under Eye rejuvenation via authorised aesthetic wholesalers.
  • Manufactured under medical Aesthetic quality systems; practitioners should confirm device classification, CE/UKCA marking and regulatory status from packaging and technical documentation.
  • Use restricted to trained healthcare or aesthetic professionals in line with local regulations governing injectable aesthetic treatments.
Under-eye polynucleotide (PN) skin booster

Description

LUMI-PRO Eyes PN Skin Booster is a targeted under-eye injectable designed to treat dark circles, puffiness and fine wrinkles in the delicate periocular area. Each 1 ml pre-filled syringe contains 5 mg/ml of polynucleotides (PN), purified DNA fragments that stimulate cellular repair and collagen production. The lightweight, non-volumising solution deeply hydrates and revitalises the under-eye skin, improving tone, texture, elasticity and overall radiance without altering natural facial contours. Intended for professional use, LUMI-PRO Eyes offers a clinically effective, minimally invasive option for patients seeking a refreshed, more youthful under-eye appearance.

Bnefits

  • Specifically formulated for the delicate under-eye and periocular area.
  • Contains 5 mg/ml of polynucleotides (PN) to stimulate cell repair and collagen production.
  • Visibly reduces dark under-eye circles and puffiness.
  • Smooths and minimises fine lines and wrinkles without adding volume.
  • Improves skin tone and texture for a brighter, more even under-eye area.
  • Restores elasticity and firmness by supporting collagen and elastin synthesis.
  • Provides deep, long-lasting hydration with a lightweight, non-bulking feel.
  • Delivers natural-looking, gradual rejuvenation with minimal downtime.
  • Suitable as a standalone biostimulatory treatment or in combination with other aesthetic procedures.
  • Professional-use product offering a targeted, non-surgical solution for tired, ageing or dehydrated under-eyes.

Indications

  • Dark under-eye circles related to skin quality and microvascular changes.
  • Under-eye puffiness and mild under-eye bags.
  • Fine lines and wrinkles around the eyes, including crow’s feet.
  • Sagging, crepey or lax under-eye skin.
  • Dull, dehydrated or tired-looking periocular skin.
  • Patients seeking subtle, natural under-eye rejuvenation without volumising filler.
  • Adjunctive treatment in a broader periocular anti-ageing protocol as determined by the practitioner.

Composition

  • Polynucleotide (PN) 5 mg/ml.
  • Deoxyribonucleic acid (DNA) 250–350 kDa.
  • Aqua (water for injection).
  • Sodium chloride.
  • Sodium DNA.
  • Sodium phosphate.
  • Other standard buffering components as listed in the internal Instructions for Use.

Formulation

  • Sterile, clear aqueous solution containing polynucleotides (PN) for intradermal use.
  • Polynucleotide concentration: 5 mg/ml in a 1 ml pre-filled syringe.
  • Non-crosslinked, non-hyaluronic acid formulation focused on biostimulation and skin quality improvement rather than volumetric filling.
  • Designed for micro-deposit/mesotherapy-style injection into the superficial to mid-dermis of the under-eye area.

Packaging

  • Each retail unit contains 1 x 1 ml pre-filled sterile syringe of LUMI-PRO Eyes PN Skin Booster.
  • Syringe supplied in a protective blister tray within branded outer carton.
  • Outer packaging labelled with product name, strength (PN 5 mg/ml), volume (1 ml), batch/lot number, expiry date and basic product information.
  • Intended for single-patient, single-use; any remaining product must be discarded after treatment.

Usage

  • For professional use only and must be administered by suitably trained healthcare or aesthetic practitioners.
  • Indicated for the under-eye/periocular region; injections should be placed in the superficial to mid-dermis using micro-deposits, serial puncture or mesotherapy-style techniques, avoiding intravascular injection.
  • Before treatment, perform a full medical history, under-eye assessment and informed consent; discuss realistic expectations and potential risks.
  • Cleanse and disinfect the periocular area thoroughly; maintain strict aseptic technique with sterile gloves, needles and equipment.
  • Use fine-gauge needles (commonly 30G or similar) to deliver small aliquots evenly under the eye, staying a safe distance from the lash line and orbital rim.
  • Most protocols recommend a course of 3–4 treatment sessions spaced approximately 2–3 weeks apart, with maintenance sessions every few months depending on individual needs and response.
  • After treatment, advise patients to avoid touching or rubbing the area, applying makeup for at least 12–24 hours, and to avoid strenuous exercise, alcohol, saunas/steam rooms and direct heat or intense sun exposure for 24–48 hours.
  • Encourage consistent daily use of a broad-spectrum SPF around the eye area (where appropriate) to protect and maintain results.
  • Schedule follow-up appointments to review outcomes, address any adverse events and plan ongoing maintenance or combination treatments.

Contraindications

  • Known hypersensitivity or allergy to polynucleotides, sodium DNA or any other component of the product.
  • Active skin infection, inflammation or disease in the intended treatment area (e.g. dermatitis, eczema, psoriasis, bacterial or viral infections such as herpes simplex).
  • History of severe allergic reactions or anaphylaxis to injectable biostimulatory products or similar treatments.
  • Uncontrolled systemic disease, significant immunosuppression or bleeding/coagulation disorders, unless carefully assessed and approved by a qualified clinician.
  • Pregnancy and breastfeeding, as elective aesthetic injectables are generally avoided due to limited safety data.
  • Previous periocular surgery, implants or permanent fillers in the treatment area that may increase the risk of complications, unless the procedure is deemed safe by an experienced practitioner.
  • Any additional contraindications and cautions stated in the manufacturer or distributor’s professional product information and in relevant local clinical guidelines.

Adverse Effects

  • Common transient reactions at the injection sites including redness, mild swelling, tenderness, superficial bruising, pinpoint bleeding and temporary itching or warmth.
  • Small papules or bumps at injection points, typically resolving within hours to a few days as the solution disperses.
  • Occasional post-treatment oedema or mild under-eye puffiness, usually short-lived.
  • Rare local inflammatory reactions or nodules that may require clinical assessment and management.
  • Risk of infection if aseptic technique is not followed or if aftercare instructions are not adhered to, potentially presenting with increasing pain, redness, warmth or discharge.
  • As with any periocular injectable, there is a very small risk of vascular compromise if product is inadvertently injected intravascularly; practitioners must be trained to recognise early warning signs (severe pain, blanching, mottling, visual changes) and initiate emergency protocols.
  • Possible hypersensitivity or allergic-type responses to one or more components, necessitating prompt clinical review.
  • Patients should be instructed to seek immediate medical advice if they experience severe or worsening pain, marked discolouration, persistent swelling, visual disturbance or signs of infection.

Storage Conditions

  • Store in the original packaging in a cool, dry place away from direct sunlight and heat sources.
  • Maintain within the temperature range specified on the packaging (commonly between 2°C and 25°C); do not freeze.
  • Keep the syringe in its protective blister until use to maintain sterility and protect from physical damage.
  • Do not use the product after the expiry date, or if the packaging, syringe or solution appears damaged, discoloured or contains visible particulates.
  • Keep out of the reach of children and unauthorised persons, in accordance with clinic storage policies for injectable products.

Duration

Supplier guidance and clinical protocols typically recommend a course of 3\u20134 sessions spaced 2\u20133 weeks apart, with results maintained through periodic top-up treatments every 6\u201312 months depending on skin quality, lifestyle and ageing rate. Individual longevity of effect may vary but improvements are generally sustained for several months after a completed course.

Onset

Initial improvements in hydration and brightness may be noticed within days to a few weeks after treatment, with progressive reductions in dark circles, puffiness and fine lines becoming more apparent over a course of sessions as collagen production and tissue repair are stimulated.

Browse more Injectable skin booster

Top Treatments

Top Cities in the UK